News archive

This project will develop a method of identifying children and young adult patients at low risk of harm when they present with febrile neutropenia, a complication of treatment for cancer. This may allow the reduction of intensity or duration of the aggressive in-patient antibiotic treatment that is currently used. The project will use individual patient data (IPD) pooled analysis, where the data from previously conducted studies are brought together and analysed to come to a more precise conclusion than any individual study could.

The project will form an international collaboration to collect the data, which will include researchers, doctors and parents. The analysis will try to find out if there are particular factors that would help predict which children have the best outcomes. It will start by looking at the simplest information (such as the age of the child, or their diagnosis) and build in more complex data (such as specialized blood test results) to see if these make the prediction more accurate. The results of this analysis will be tested, and the potential economic effects estimated.

The methods used in performing IPD analysis will also be investigated, advancing our understanding of how best to conduct such studies.

Collaborators in Leeds, London, Switzerland and Germany have already agreed to take part, and it is hoped this will become a truly global study to improve patient care.